Sarepta Therapeutics, Inc. · NASDAQ:SRPT
The Vanguard Group reported a 10.89% stake in Sarepta Therapeutics, Inc. (Schedule 13G/A)
Event Aug 29, 2025 · Filed Sep 8, 2025
The Vanguard Group reported a 10.89% stake in Sarepta Therapeutics, Inc., 10,641,733 shares, as a passive investor on Aug 29, 2025. Filed Sep 8, 2025 (Schedule 13G/A).
- Stake
- 10.89%
- Shares
- 10,641,733
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 10.89% | 10,641,733 |
Source
Related
- Sarepta Therapeutics, Inc.
- The Vanguard Group
- Sarepta Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Wong Ryan Ho-Yan · Sep 8, 2026
- Form 4 · Estepan Ian Michael · Sep 8, 2026
- Form 4 · Rothfuss Cristin · Sep 8, 2026
- Form 4 · Rodino-Klapac Louise · Sep 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 13, 2026